Viracta Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Viracta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viracta Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Viracta Therapeutics by Morgan Stanley
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $73k | 135k | 0.54 |
2024-03-31 | $120k | 118k | 1.02 |
2023-12-31 | $50k | 87k | 0.57 |
2023-09-30 | $63k | 60k | 1.04 |
2023-06-30 | $83k | 59k | 1.41 |
2022-12-31 | $62k | 62k | 1.00 |
2022-06-30 | $403k | 88k | 4.57 |
2022-03-31 | $325k | 68k | 4.80 |
2021-06-30 | $0 | 36k | 0.00 |